Skip to main content

Allergan purchases Aczone from QLT


IRVINE, Calif. Allergan sales, a wholly owned subsidiary of Allergan has completed its acquisition of Aczone gel 5 percent from QLT USA, according to published reports.

Aczone is a topical treatment for acne vulgaris. Allergan paid about $150 million for all assets relating to the Aczone product.

Allergan expects to launch the drug in the fourth quarter of 2008 in the U.S. and Canada.

This ad will auto-close in 10 seconds